Related Experiment Video
Updated: Jul 5, 2026

Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time
Published on: May 20, 2014
Expression of c-kit and platelet-derived growth factor receptors in ovarian granulosa cell tumors
Rodney P Rocconi1, Kellie S Matthews, Kristopher J Kimball
1Department of Obstetrics and Gynecology, University of South Alabama Mitchell Cancer Institute, Mobile, Alabama 36607, USA. rocconi@usouthal.edu
Objective:
This study aimed at evaluating the expression of tyrosine kinase receptors c-kit, (platelet-derived growth factor receptor-alpha (PDGFR-alpha), and PDGFR-beta in ovarian granulosa cell tumors (GCTs).
Study Design:
Primary ovarian GCT specimens were obtained for immunohistochemical staining.The expressions of c-kit, PDGFR-alpha, and PDGFR-beta were analyzed and scored by a semiquantitative (SQ) method. Normal ovarian tissue from the same patients' specimens served as internal controls.
Results:
A total of 21 specimens were available for evaluation. C-kit was expressed in only 2 samples, whereas both PDGFR-alpha and PDGFR-beta stained positive in 100% of tumors. PDGFR targets demonstrated strong positive expression in intensity and amount of tissue stained. Normal ovarian tissue demonstrated complete absence of staining for all 3 antibodies evaluated.
Conclusions:
The data demonstrated significant expression of PDGFR targets of imatinib mesylate in GCTs, whereas normal ovarian tissues had a complete absence of staining.This expression profile provides the rationale to investigate the role of imatinib mesylate in PDGFR-positive GCTs.
Insights
Platelet-derived growth factor receptors (PDGFR-alpha and PDGFR-beta) are highly expressed in ovarian granulosa cell tumors (GCTs). This suggests imatinib mesylate may be a potential targeted therapy for GCTs.
Area of Science:
- Oncology
- Molecular Biology
- Gynecologic Pathology
Background:
- Ovarian granulosa cell tumors (GCTs) are rare neoplasms.
- Understanding the molecular targets within GCTs is crucial for developing targeted therapies.
Purpose of the Study:
- To evaluate the expression of tyrosine kinase receptors c-kit, platelet-derived growth factor receptor-alpha (PDGFR-alpha), and PDGFR-beta in ovarian GCTs.
- To assess the potential of targeting these receptors with imatinib mesylate.
Main Methods:
- Immunohistochemical staining was performed on 21 primary ovarian GCT specimens.
- Expression levels of c-kit, PDGFR-alpha, and PDGFR-beta were analyzed using a semiquantitative scoring method.
- Normal ovarian tissue served as internal controls.
Main Results:
- C-kit expression was observed in only 2 out of 21 GCT specimens.
- PDGFR-alpha and PDGFR-beta were expressed in 100% of GCT specimens with strong intensity.
- No staining for c-kit, PDGFR-alpha, or PDGFR-beta was detected in normal ovarian tissues.
Conclusions:
- Significant expression of PDGFR targets was found in GCTs, contrasting with normal ovarian tissues.
- The high expression of PDGFRs in GCTs supports further investigation into imatinib mesylate as a targeted therapeutic agent.
Related Concept Videos
Mitogens and the Cell Cycle
Folliculogenesis

